Emami has acquired Axiom Ayurveda for about ₹200 crore, marking a strategic push into the health and wellness segment as consumer demand for natural and functional beverages rises across India.
Full acquisition strengthens portfolio
Emami, the Kolkata-headquartered FMCG company, has taken 100% ownership of Axiom Ayurveda in a deal valued at around ₹200 crore. The acquisition follows Emami’s earlier minority stake taken in 2023 and reflects confidence in Axiom’s growth trajectory and brand equity.
Axiom Ayurveda is known for its aloe vera‑based beverage AloFrut and a range of ayurvedic juices that have won traction among health‑conscious consumers. The move adds a fast‑growing beverage category to Emami’s predominantly personal‑care portfolio.
Strategic rationale and market context
Indian consumers have steadily shifted towards healthier beverage options, including herbal juices, functional drinks and formulations rooted in traditional medicine systems such as Ayurveda. What were once niche segments are now entering the mainstream, driven by rising health awareness and urbanisation.
For Emami, the acquisition enables scaling of manufacturing, wider distribution and accelerated marketing for Axiom’s products. The company’s established supply chain and retail relationships are likely to help the brand penetrate both urban retail and smaller town and rural markets.
Financials and growth prospects
Axiom Ayurveda has crossed annual revenues of around ₹100 crore. Industry observers expect that under Emami’s stewardship the brand could expand faster through capital infusion, expanded production capacity and broader shelf presence.
Beyond immediate revenue uplift, the acquisition signals Emami’s broader strategy to diversify away from traditional personal‑care lines and build a stronger foothold in the future‑oriented wellness and functional foods segment.
